Wayne Holman, Ridgeback Capital

Wayne Holman, MD, is the founder and CEO of Ridgeback Capital. See contact routes.

About Wayne Holman

Wayne Holman, MD, is the founder and CEO of Ridgeback Capital, a New York-based firm that invests across all stages—from Friends & Family and pre-seed to IPO—in life science and biopharma companies developing life-saving therapies. His distinctive thesis centers on providing “patient capital” to support paradigm-changing technologies that address unmet medical needs in healthcare. While specific check sizes are not publicly disclosed, the firm has funded over 100 biopharma companies, with notable portfolio exits including Turnstone Biologics and recent PIPE investments in Pyxis Oncology. Holman, a physician-investor and Clinical Professor at NYU Langone, leverages his medical background to identify innovations with broad societal impact.

Wayne Holman at a glance

Role
Managing Director
Organization
Ridgeback Capital
Location
New York, New York, United States
Investor type
Venture Capital

Frequently asked about Wayne Holman

What does Wayne Holman invest in?
We have not verified a stated sector or stage focus for Wayne Holman at Ridgeback Capital (New York, New York, United States). The profile lists the organization, location and investors we track alongside them.
How do I contact Wayne Holman?
Wayne Holman's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Wayne Holman based?
Wayne Holman is based in New York, New York, United States.

StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in New York.

Investors similar to Wayne Holman (20)

Browse related investor lists (2)

Compare Wayne Holman (8)

Investors like Wayne Holman · Full investor directory · Investor access · Company funding database